Skip to content

The study on the hydrogel microparticles inhibits absorption of ethylalcohol

The study on the hydrogel microparticles inhibits absorption of ethylalcohol

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500102820
Enrollment
Unknown
Registered
2025-05-20
Start date
2025-05-28
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood and breath alcohol metabolism

Interventions

Group A (hydrogel microparticles - placebo):hydrogel microparticles- placebo
Group B (placebo-hydrogel microparticles):placebo-hydrogel microparticles

Sponsors

Shanghai Fengxian District Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. The age of the subjects was between 18~45 years old. 2. Alcohol is not allowed within 3 days prior to the trial. 3. Those who have no obvious systemic diseases (including physical, mental and social), and the measurement indicators are within the normal measurement range or have no clinically significant mild abnormalities judged by the investigator, that is, subjects participating in clinical trials who are in good health. 4. The subject voluntarily participates in this clinical study and completes the written informed consent signing.

Exclusion criteria

Exclusion criteria: 1. Presence (or existence) of a history of alcohol addiction. 2. Known hypersensitivity to hydrogel microparticles or alcohol. 3. Pregnancy or breastfeeding. 4. People with obesity, diabetes, hypertension, coronary heart disease, liver and kidney insufficiency, tumors, kidney failure, cerebral hemorrhage, stroke, cardiopulmonary insufficiency, myocardial infarction, cardiac stents, artificial pacemakers. 5. Those with mental illness and loss of independent mobility.

Design outcomes

Primary

MeasureTime frame
blood alcohol level;breath alcohol level;

Secondary

MeasureTime frame
alanine aminotransferase;blood glucose;aspartate aminotransferase;

Countries

China

Contacts

Public ContactHaoyong Yu

Shanghai Fengxian District Central Hospital

yuhaoyong111@163.com+86 21 24058337

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026